Magnesium in man: Implications for health and disease

Physiological Reviews

Volumn 95, Issue 1, 2015, Pages 1-46

  de Baaij, Jeroen H F ^a   Hoenderop, Joost G J ^a   Bindels, René J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CALCINEURIN INHIBITOR; CALCIUM ION; CARRIER PROTEIN; CLAUDIN; CLAUDIN 16; CYCLIN DEPENDENT KINASE 5; CYCLIN M2; CYCLINE; DIURETIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; INSULIN RECEPTOR; MAGNESIUM; MAGNESIUM ION; MAGNESIUM TRANSPORTER 1; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL RNA SPLICING 2 PROTEIN; PARVALBUMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN SLC41A1; PROTON PUMP INHIBITOR; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSFER RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL M1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT;

ARTICLE; ASTHMA; BLOOD VESSEL CALCIFICATION; BONE; BRAIN; BRAIN INJURY; CELL MEMBRANE; CELL VIABILITY; CELLULAR IMMUNODEFICIENCY; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; CYSTIC FIBROSIS; DEPRESSION; DIABETES MELLITUS; DRUG INDUCED DISEASE; EPILEPSY; EPILEPTIC STATE; GENE MUTATION; GOLGI MEMBRANE; HEART; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HENLE LOOP; HOMEOSTASIS; HUMAN; HYPERMAGNESEMIA; HYPERTENSION; HYPOMAGNESEMIA; IMMUNITY; INTERACTIONS WITH RNA; INTESTINE ABSORPTION; INTRACELLULAR SIGNALING; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; LARGE INTESTINE; LIVER FUNCTION; LUNG DISEASE; METABOLISM; MIGRAINE; MITOCHONDRIAL MEMBRANE; MUSCLE CRAMP; NEUROPATHOLOGY; NONHUMAN; OSTEOPOROSIS; PANCREAS FUNCTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PREECLAMPSIA; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; SKELETAL MUSCLE; SMALL INTESTINE; SUBARACHNOID HEMORRHAGE; SUPPLEMENTATION; T LYMPHOCYTE; TORSADE DES POINTES; TRAUMATIC BRAIN INJURY; VASCULARIZATION; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CELL PROLIFERATION; DIGESTIVE SYSTEM; KIDNEY; LUNG; MAGNESIUM DEFICIENCY; MUSCLE; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

BONE AND BONES; BRAIN; CARDIOVASCULAR SYSTEM; CELL COMMUNICATION; CELL PROLIFERATION; DIGESTIVE SYSTEM; HUMANS; KIDNEY; LUNG; MAGNESIUM; MAGNESIUM DEFICIENCY; MUSCLES; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84919782110     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00012.2014     Document Type: Article

References (593)

1. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press, 1997.
2. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 360: 1189-1196, 2002.
3. Expert Panel Report 3 (E.P.R.-3): Guidelines for the Diagnosis, and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 120: S94–138, 2007.
4. ISIS4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival). Collaborative Group Lancet 345: 669-685, 1995.
5. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. Br J Obstet Gynaecol 114: 289-299, 2007.
6. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. Br J Obstet Gynaecol 114: 300-309, 2007.
7. Abbott L, Nadler J, Rude RK. Magnesium deficiency in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcoholism Clin Exp Res 18: 1076-1082, 1994.
8. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, Yano K, Curb JD. Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 92: 665-669, 2003.
9. Abraham AS, Eylath U, Weinstein M, Czaczkes E. Serum magnesium levels in patients with acute myocardial infarction. N Engl J Med296: 862-863, 1977.
10. Abraham GE. The importance of magnesium in the management of primary postmenopausal osteoporosis. J Nutr Environ Med2: 165-178, 1991.
11. Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, Hennekam RC, Ledermann SE, Rees L, van’t Hoff W, Marks SD, Trompeter RS, Tullus K, Winyard PJ, Cansick J, Mushtaq I, Dhillon HK, Bingham C, Edghill EL, Shroff R, Stanescu H, Ryffel GU, Ellard S, Bockenhauer D. HNF1B mutations associate with hypomagnesemiaand renal magnesium wasting. J Am Soc Nephrol 20: 1123-1131, 2009.
12. Adelman JP, Bond CT, Pessia M, Maylie J. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron15: 1449-1454, 1995.
13. Alderton A, Davies P, Illman K, Brown DR. Ancient conserved domain protein-1 binds copper and modifies its retention in cells. J Neurochem103: 312-321,2007.
14. Alfrey AC, Miller NL, Trow R. Effect of age and magnesium depletion on bone magnesium pools in rats. J Clin Invest54: 1074-1081, 1974.
15. Allouche D, Parello J, Sanejouand YH. Ca2+/Mg2+ exchange in parvalbumin and other EF-hand proteins. A theoretical study. J MolBiol 285: 857-873, 1999.
16. Altundag K, Altundag O, Baptista MZ, Turen S, Atik MA. Re: Cetuximab therapy and symptomatic hypomagnesemia.J Natl Cancer Inst 97: 1791-1792, 2005.
17. Altura BM, Gebrewold A, Zhang A, Altura BT. Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. Neu-rosci Lett341: 189-192,2003.
18. Altura BT, Altura BM. Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol91: 449-451, 1987.
19. Altura BT, Memon ZI, Zhang A, Cheng TP, Silverman R, Cracco RQ, Altura BM. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells. Neurosci Lett230: 37-40, 1997.
20. Amasheh S, Fromm M, Gunzel D. Claudins of intestine and nephron: a correlation of molecular tight junction structure and barrier function. Acta Physiol201: 133-140, 2011.
21. Amin M, Abdel-Fattah M, Zaghloul SS. Magnesium concentration in acute asthmatic children. IranianJ Pediatr22: 463-467, 2012.
22. Anastassopoulou J, Theophanides T. Magnesium-DNA interactions and the possible relation of magnesium to carcinogenesis. Irradiation and free radicals. Crit Rev Oncol/ Hematol 42: 79-91, 2002.
23. Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int50: 1110-1117, 1996.
24. Angelow S, El-Husseini R, Kanzawa SA, Yu AS. Renal localization and function of the tight junction protein, claudin-19. Am J Physiol Renal Physiol293: F166–F177, 2007.
25. Arango MF, Bainbridge D. Magnesium for acute traumatic brain injury. Cochrane Database Systematic Rev CD005400, 2008.
26. Ariza AC, Bobadilla N, Diaz L, Avila E, Larrea F, Halhali A. Placental gene expression of calcitonin gene-related peptide and nitric oxide synthases in preeclampsia: effects of magnesium sulfate. Magnesium Res22: 44-49, 2009.
27. Ariza AC, Ponce X, Gonzalez-Gonzalez ME, Larrea F, Halhali A. Effects of magnesium sulphate on placental expression of endothelin 1 and its receptors in preeclampsia. Clin Biochem40: 976-980, 2007.
28. Arjona FJ, De Baaij JHF, Schlingmann KP, Lameris ALL, Van Wijk E, Flik G, Regele S, Korenke GC, Nephytou B, Rust S, Reintjes N, Konrad M, Bindels RJM, Hoenderop JGJ. CNNM2 Mutations cause Impaired Brain Development and Seizures in Patients with Hypomagnesemia. PLoS Genet10: e1004267, 2014.
29. Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, Nakao T, Oka-mura M, Kim S, Iwao H, Miura K. Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation74: 784-791, 2002.
30. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, Witteman J, Stampfer MJ. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension27: 1065-1072, 1996.
31. Aziz HS, Blamoun AI, Shubair MK, Ismail MM, DeBari VA, Khan MA. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. Ann Clin Lab Sci35: 423-427, 2005.
32. Bairoch A. The ENZYME database in 2000. Nucleic Acids Res28: 304-305, 2000.
33. Ban C, Junop M, Yang W. Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell97: 85-97, 1999.
34. Bandulik S, Schmidt K, Bockenhauer D, Zdebik AA, Humberg E, Kleta R, Warth R, Reichold M. The salt-wasting phenotype of EAST syndrome, a disease with multifac-eted symptoms linked to the KCNJ10 K+ channel. Pflügers Arch461: 423-435, 2011.
35. Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry20: 163-171, 1985.
36. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys458: 40-47, 2007.
37. Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnesium Res21:218-223, 2008.
38. Barton CH, Pahl M, Vaziri ND, Cesario T. Renal magnesium wasting associated with amphotericin B therapy. Am J Med77: 471-474, 1984.
39. Barton CH, Vaziri ND, Martin DC, Choi S, Alikhani S. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Am J Med83: 693-699, 1987.
40. Bartter FC, Pronove P, Gill JRJr, Maccardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med33: 811-828, 1962.
41. Barzilay G, Mol CD, Robson CN, Walker LJ, Cunningham RP, TainerJA, Hickson ID. Identification of critical active-site residues in the multifunctional human DNA repair enzyme HAP1. Nature Struct Biol2: 561-568, 1995.
42. Bates-Withers C, Sah R, Clapham DE. TRPM7, the Mg2+ inhibited channel and kinase. Adv Exp Med Biol704: 173-183, 2011.
43. Bednarek A, Pasternak K, Karska M. Evaluation of blood serum, erythrocyte and urine magnesium concentrations in babies with pneumonia or bronchial obstructive bronchitis. Magnesium Res16: 271-280, 2003.
44. Belge H, Gailly P, Schwaller B, Loffing J, Debaix H, Riveira-Munoz E, Beauwens R, Devogelaer JP, Hoenderop JG, Bindels RJ, Devuyst O. Renal expression of paralbumin is critical for NaCl handling and response to diuretics. Proc Natl Acad Sci USA 104: 14849-14854, 2007.
45. Ben-Yosef T, Belyantseva IA, Saunders TL, Hughes ED, Kawamoto K, Van Itallie CM, Beyer LA, Halsey K, Gardner DJ, Wilcox ER, Rasmussen J, Anderson JM, Dolan DF, Forge A, Raphael Y, Camper SA, Friedman TB. Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet12: 2049-2061, 2003.
46. Bhatt SP, Khandelwal P, Nanda S, Stoltzfus JC, Fioravanti GT. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respir Med102: 999-1003,2008.
47. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22: 345-353, 2002.
48. Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache53: 1230-1244, 2013.
49. Bilbey DL, Prabhakaran VM. Muscle cramps and magnesium deficiency: case reports. Canadian Family Physician42: 1348-1351, 1996.
50. Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, Beekmann F, Fekete A, Omran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NV, Antignac C, Sudbrak R, Kispert A, Hildebrandt F. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nature Genet29: 310-314, 2001.
51. Birmingham CL, Gritzner S. Heart failure in anorexia nervosa: case report and review of the literature. Eating Weight Disorders 12: e7–10, 2007.
52. Birrer RB, Shallash AJ, Totten V. Hypermagnesemia-induced fatality following epsom salt gargles(1).J Emergency Med 22: 185-188, 2002.
53. Blackfan KD, Hamilton B. Uremia in acute glomerular nephritis: the cause and treatment in children. Boston Med SurgJ193: 617-621, 1925.
54. Bockenhauer D, Feather S, Stanescu HC, Bandulik S, Zdebik AA, Reichold M, Tobin J, Lieberer E, Sterner C, Landoure G, Arora R, Sirimanna T, Thompson D, Cross JH, van’t Hoff W, Al Masri O, Tullus K, Yeung S, Anikster Y, Klootwijk E, Hubank M, Dillon MJ, Heitzmann D, Arcos-Burgos M, Knepper MA, Dobbie A, Gahl WA, Warth R, Sheridan E, Kleta R. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 360: 1960-1970, 2009.
55. Boyman L, Mikhasenko H, HillerR, Khananshvili D. Kinetic and equilibrium properties of regulatory calcium sensors of NCX1 protein. J Biol Chem284: 6185-6193, 2009.
56. Brautigam CA, Steitz TA. Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr Opin Struct Biol8: 54-63, 1998.
57. Breiderhoff T, Himmerkus N, Stuiver M, Mutig K, Will C, Meij IC, Bachmann S, Bleich M, Willnow TE, Muller D. Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs paracellular sodium permeability and leads to hypermagnesemia and nephro-calcinosis. Proc Natl Acad Sci USA109: 14241-14246,2012.
58. Breukels V, Konijnenberg A, Nabuurs SM, Touw WG, Vuister GW. The second Ca2+-binding domain of NCX1 binds Mg2+ with high affinity. Biochemistry50: 8804-8812, 2011.
59. Briel RC, Lippert TH, Zahradnik HP. Action of magnesium sulfate on platelet prostacyclin interaction and prostacyclin of blood vessels. Am J Obstet Gynecol153: 232, 1985.
60. Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet344: 357-362, 1994.
61. Brodowski J. Levels of ionized magnesium in women with various stages of postmenopausal osteoporosis progression evaluated on the basis of densitometric examinations. Przeglad lekarski57: 714-716, 2000.
62. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nature Genet8: 136-140, 1994.
63. Brunet S, Scheuer T, Klevit R, Catterall WA. Modulation of CaV1.2 channels by Mg2+ acting at an EF-hand motif in the COOH-terminal domain.J Gen Physiol 126: 311-323, 2005.
64. Brunette MG, Vigneault N, Carriere S. Micropuncture study of magnesium transport along the nephron in the young rat. Am J Physiol227: 891-896, 1974.
65. Burnett RJ, Reents SB. Severe hypomagnesemia induced by pentamidine. Ann Pharmacotherapy24: 239-240, 1990.
66. Cairo ER, Friedrich T, Swarts HG, Knoers NV, Bindels RJ, Monnens LA, Willems PH, De Pont JJ, Koenderink JB. Impaired routing of wild type FXYD2 after oligomerisation with FXYD2-G41R might explain the dominant nature of renal hypomagnesemia. Biochim Biophys Acta 1778: 398-404,2008.
67. Cairo ER, Swarts HG, Wilmer MJ, Willems PH, Levtchenko EN, De PontJJ, KoenderinkJB. FXYD2 and Na,K-ATPase expression in isolated human proximal tubular cells: disturbed upregulation on renal hypomagnesemia? J Membr Biol231:117-124, 2009.
68. Calsou P, Salles B. Properties of damage-dependent DNA incision by nucleotide excision repair in human cell-free extracts. Nucleic Acids Res22: 4937-4942, 1994.
69. Cao G, Hoenderop JG, Bindels RJ. Insight into the molecular regulation of the epithelial magnesium channel TRPM6. Curr Opin Nephrol Hypertens 17: 373-378, 2008.
70. Cao G, Thebault S, van der Wijst J, van der Kemp A, Lasonder E, Bindels RJ, Hoen-derop JG. RACK1 inhibits TRPM6 activity via phosphorylation of the fused alpha-kinase domain. Curr Biol 18: 168-176,2008.
71. Cao G, van der Wijst J, van der Kemp A, van Zeeland F, Bindels RJ, Hoenderop JG. Regulation of the epithelial Mg2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA). J Biol Chem 284: 14788-14795, 2009.
72. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregorGA Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J 291:235-238, 1985.
73. Caspi R, Altman T, Dreher K, Fulcher CA, Subhraveti P, Keseler IM, Kothari A, Krummenacker M, Latendresse M, Mueller LA, Ong Q, Paley S, Pujar A, Shearer AG, Travers M, Weerasinghe D, Zhang P, Karp PD. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res 40: D742-753, 2012.
74. Castiglioni S, Maier JA. Magnesium and cancer: a dangerous liason. Magnesium Res 24: S92–100, 2011.
75. Cefaratti C, Young A, Romani A. Effect of ethanol administration on Mg2+ transport across liver plasma membrane. Alcohol36: 5-18, 2005.
76. Ceremuzynski L, Jurgiel R, Kulakowski P, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J118: 1333-1334, 1989.
77. Cernak I, Savic VJ, Kotur J, Prokic V, Veljovic M, Grbovic D. Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J Neurotrauma17: 53-68, 2000.
78. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia25: 199-204, 2005.
79. Chaigne-Delalande B, Li FY, O’Connor GM, Lukacs MJ, Jiang P, Zheng L, Shatzer A, Biancalana M, Pittaluga S, Matthews HF, Jancel TJ, Bleesing JJ, Marsh RA, Kuijpers TW, Nichols KE, Lucas CL, Nagpal S, Mehmet H, Su HC, Cohen JI, Uzel G, Lenardo MJ. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341: 186-191, 2013.
80. Chandler LJ, Guzman NJ, Sumners C, Crews FT. Magnesium and zinc potentiate ethanol inhibition of N-methyl-D-aspartate-stimulated nitric oxide synthase in cortical neurons. J Pharmacol Exp Ther271: 67-75, 1994.
81. Chanimov M, Berman S, Gofman V, Weissgarten Y, Averbukh Z, Cohen ML, Vitin A, Bahar M. Total cell associated electrolyte homeostasis in rat spinal cord cells following apparently irreversible injury. Medical Science Monitor 12: BR63-67, 2006.
82. Chen YZ, Gao Q, Zhao XZ, Chen YZ, Bennett CL, Xiong XS, Mei CL, Shi YQ, Chen XM. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/ maturity onset diabetes of the young type 5. ChineseMedJ123: 3326-3333,2010.
83. Cheng PT, Grabher JJ, LeGeros RZ. Effects of magnesium on calcium phosphate formation. Magnesium7: 123-132, 1988.
84. Chernow B, Bamberger S, Stoiko M, Vadnais M, Mills S, Hoellerich V, Warshaw AL. Hypomagnesemia in patients in postoperative intensive care. Chest95: 391-397, 1989.
85. Chiu TK, Dickerson RE. 1 A crystal structures of B-DNA reveal sequence-specific binding and groove-specific bending of DNA by magnesium and calcium. J Mol Biol301: 915-945, 2000.
86. Choi H, Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emergency Medicine21: 2-9,2014.
87. Clarke RJ, Johnson JW. NMDA receptor NR2 subunit dependence of the slow component of magnesium unblock. J Neurosci26: 5825-5834, 2006.
88. Cochrane DE, Douglas WW. Histamine release by exocytosis from rat mast cells on reduction of extracellular sodium: a secretory response inhibited by calcium, strontium, barium or magnesium. J Physiol257: 433-448, 1976.
89. Cohen L, Kitzes R. Infrared spectroscopy and magnesium content of bone mineral in osteoporotic women. Israel J Med Sci17: 1123-1125, 1981.
90. Cohen L, Laor A. Correlation between bone magnesium concentration and magnesium retention in the intravenous magnesium load test. Magnesium Res3: 271-274, 1990.
91. Cohen L, Laor A, Kitzes R. Bone magnesium, crystallinity index and state of body magnesium in subjects with senile osteoporosis, maturity-onset diabetes and women treated with contraceptive preparations. Magnesium2: 70-75, 1983.
92. Cohen N, Almoznino-Sarafian D, Zaidenstein R, Alon I, Gorelik O, Shteinshnaider M, Chachashvily S, Averbukh Z, Golik A, Chen-Levy Z, Modai D. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. Heart 89: 411-416, 2003.
93. Cook RC, Yamashita MH, Kearns M, Ramanathan K, Gin K, Humphries KH. Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a metaanalysis. Ann Thoracic Surg95: 533-541, 2013.
94. Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emergency Med38: 621-627, 2001.
95. Cowan JA. The Biological Chemistry of Magnesium. New York: VCH Publishers, 1995.
96. Cross JH, Arora R, Heckemann RA, Gunny R, Chong K, Carr L, Baldeweg T, Differ AM, Lench N, Varadkar S, Sirimanna T, Wassmer E, Hulton SA, Ognjanovic M, Ramesh V, Feather S, Kleta R, Hammers A, Bockenhauer D. Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome. DevMed Child Neurol55: 846-856, 2013.
97. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol11: 327-335, 2001.
98. Curiel-Garcia JA, Rodriguez-Moran M, Guerrero-Romero F. Hypomagnesemia and mortality in patients with type 2 diabetes. Magnesium Res21:163-166, 2008.
99. Curry DL, Joy RM, Holley DC, Bennett LL. Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology101: 203-208, 1977.
100. Da Silva CA, de Braganca AC, Shimizu MH, Sanches TR, Fortes MA, Giorgi RR, Andrade L, Seguro AC. Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression. Am J Physiol Renal Physiol297: F916-F922, 2009.
101. Davies DL, Fraser R. Do diuretics cause magnesium deficiency? Br J Clin Pharmacol36: 1-10, 1993.
102. Davy H. Electro-chemical researches, on the decomposition of the earths; with observations on the metals obtained from the alkaline earths, and on the amalgam procured from ammonia. Philos Trans R Soc Lond98: 333-370, 1808.
103. De Baaij JH, Blanchard MG, Lavrijsen M, Leipziger J, Bindels RJ, Hoenderop JG. P2X4 receptor regulation of transient receptor potential melastatin type 6 (TRPM6) Mg channels. Pflügers Arch466: 1941-1952, 2014.
104. De Baaij JH, Groot Koerkamp MJ, Lavrijsen M, van Zeeland F, Meijer H, Holstege FC, Bindels RJ, Hoenderop JG. Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal magnesium handling. Am J Physiol Renal Physiol305: F1563–F1573, 2013.
105. De Baaij JH, Stuiver M, Meij IC, Lainez S, Kopplin K, Venselaar H, Muller D, Bindels RJ, Hoenderop JG. Membrane topology and intracellular processing of cyclin M2 (CNNM2).J Biol Chem 287: 13644-13655, 2012.
106. De Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodi-alysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dialysis Transplant25: 3707-3717, 2010.
107. De Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Cangucu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 21: 682-686, 1998.
108. DeOliveira GS Jr, Knautz JS, Sherwani S, McCarthy RJ. Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. J Cardiothoracic Vasc Anesthesia26: 643-650, 2012.
109. De Valk HW, Kok PT, Struyvenberg A, van Rijn HJ, Haalboom JR, Kreukniet J, Lam-mers JW. Extracellular and intracellular magnesium concentrations in asthmatic patients. Eur RespirJ6: 1122-1125, 1993.
110. Deason-Towne F, Perraud AL, Schmitz C. The Mg2+ transporter MagT1 partially rescues cell growth and Mg2+ uptake in cells lacking the channel-kinaseTRPM7. FEBS Lett585: 2275-2278, 2011.
111. DeGraba TJ, Pettigrew LC. Why do neuroprotective drugs work in animals but not humans? Neurol Clinics18: 475-493, 2000.
112. Demirkaya S, Vural O, Dora B, Topcuoglu MA. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache41: 171-177, 2001.
113. Denis W. Determination of magnesium in blood. J Biol Chem41: 363-365, 1920.
114. Derom ML, Sayon-Orea C, Martinez-Ortega JM, Martinez-Gonzalez MA. Magnesium and depression: a systematic review. Nutr Neurosci 16: 191-206, 2013.
115. Desai BN, Krapivinsky G, Navarro B, Krapivinsky L, Carter BC, Febvay S, Delling M, Penumaka A, Ramsey IS, Manasian Y, Clapham DE. Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev Cell 22: 1149-1162, 2012.
116. Dhandapani SS, Gupta A, Vivekanandhan S, Sharma BS, Mahapatra AK. Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury. Indian J Neurotrauma5: 27-33, 2008.
117. Dias JM, Szegedi C, Jona I, Vogel PD. Insights into the regulation of the ryanodine receptor: differential effects of Mg2+ and Ca2+ on ATP binding. Biochemistry45: 9408-9415, 2006.
118. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 311: 187-191, 1992.
119. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, Mason J. Magnesium supplementation forthe management of essential hypertension in adults. Cochrane Database of Systematic RevCD004640, 2006.
120. Diederichs F. Ion homeostasis and the functional roles of SERCA reactions in stimulus-secretion coupling of the pancreatic beta-cell: a mathematical simulation. Biophys Chem134: 119-143,2008.
121. Dimke H, Desai P, Borovac J, Lau A, Pan W, Alexander RT. Activation of the Ca2+-sensing receptor increases renal claudin-14 expression and urinary Ca2+ excretion. Am J Physiol Renal Physiol304: F761-F769, 2013.
122. Dimke H, van der Wijst J, Alexander TR, Meijer IM, Mulder GM, van Goor H, Tejpar S, Hoenderop JG, Bindels RJ. Effects of the EGFR Inhibitor Erlotinib on Magnesium Handling. J Am Soc Nephrol 21:1309-1316, 2010.
123. Do Amaral AF, Rodrigues-Junior AL, Terra Filho J, Vannucchi H, Martinez JA. Effects of acute magnesium loading on pulmonary function of stable COPD patients. Med Sci Monitor14: CR524-529, 2008.
124. Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, BoitenJ, van Oostenbrugge RJ, Al-Shahi Salman R, Lavados PM, Rinkel GJ, van den Bergh WM. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet380: 44-49, 2012.
125. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Systematic RevCD000277, 2007.
126. Dorsch NW. Cerebral arterial spasm-a clinical review. Br J Neurosurg9: 403-412, 1995.
127. Duarte CG. Effects of ethacrynic acid and furosemide on urinary calcium, phosphate and magnesium. Metab Clin Exp17: 867-876, 1968.
128. Duchatelle-Gourdon I, Hartzell HC, Lagrutta AA. Modulation of the delayed rectifier potassium current in frog cardiomyocytes by beta-adrenergic agonists and magnesium. J Physiol415: 251-274, 1989.
129. Ducker CE, Stettler EM, French KJ, Upson JJ, Smith CD. Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase. Oncogene23: 9230-9237, 2004.
130. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Systematic RevCD000025, 2010.
131. Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Systematic RevCD000128, 2010.
132. Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Systematic RevCD000127, 2010.
133. Ebel H, GuntherT. Magnesium metabolism: a review. J Clin Chem Clin Biochem18: 257-270, 1980.
134. Ebel H, Hollstein M, Gunther T. Role of the choline exchanger in Na+-independent Mg2+ efflux from rat erythrocytes. Biochim Biophys Acta1559: 135-144, 2002.
135. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Medical Hypotheses67: 362-370, 2006.
136. Edwards L, Shirtcliffe P, Wadsworth K, Healy B, Jefferies S, Weatherall M, Beasley R, Team obotMCS. Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial. Thorax68: 338-343, 2013.
137. Eimerl S, Schramm M. The quantity of calcium that appears to induce neuronal death. J Neurochem62: 1223-1226, 1994.
138. Eisinger J, Clairet D. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study. Magnesium Res6: 247-249, 1993.
139. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnesium Res23: S194–198, 2010.
140. Ellison DH. The voltage-gated K+ channel subunit Kv1.1 links kidney and brain. J Clin Invest119: 763-766, 2009.
141. Emelyanov A, Fedoseev G, Barnes PJ. Reduced intracellular magnesium concentrations in asthmatic patients. Eur RespirJ13: 38-40, 1999.
142. English MW, Skinner R, Pearson AD, Price L, Wyllie R, Craft AW. Dose-related nephrotoxicity of carboplatin in children. Br J Cancer81: 336-341, 1999.
143. Enya M, Kanoh Y, Mune T, Ishizawa M, Sarui H, Yamamoto M, Takeda N, Yasuda K, Yasujima M, Tsutaya S, Takeda J. Depressive state and paresthesia dramatically improved by intravenous MgSO4 in Gitelman’s syndrome. Intern Med43: 410-414, 2004.
144. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med355: 1834-1836,2006.
145. Escuela MP, Guerra M, Anon JM, Martinez-Vizcaino V, Zapatero MD, Garcia-Jalon A, Celaya S. Total and ionized serum magnesium in critically ill patients. Intensive Care Med31: 151-156,2005.
146. Eunson LH, Rea R, Zuberi SM, Youroukos S, Panayiotopoulos CP, Liguori R, Avoni P, McWilliam RC, Stephenson JB, Hanna MG, Kullmann DM, Spauschus A. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol48: 647-656, 2000.
147. Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke40: 1169-1175, 2009.
148. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol 16: 968-981, 2009.
149. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache31:298-301, 1991.
150. Farouque HM, Sanders P, Young GD. Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease. Am J Cardiol86: 1270-1272, 2000.
151. Fei X, Hongxiang Z, Qi C, Daozhen C. Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 andtHcy in pre-eclampsia. Adv Clin Exp Med 21: 573-579, 2012.
152. Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Dello Russo A, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiology81: 25-33, 1992.
153. Ferre S, Baldoli E, Leidi M, Maier JA. Magnesium deficiency promotes a pro-athero-genic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta 1802:952-958,2010.
154. Ferre S, de Baaij JH, Ferreira P, Germann R, de Klerk JB, Lavrijsen M, van Zeeland F, Venselaar H, Kluijtmans LA, Hoenderop JG, Bindels RJ. Mutations in PCBD1 Cause Hypomagnesemia and Renal Magnesium Wasting. J Am Soc Nephrol 25: 574-586, 2014.
155. Ferre S, Veenstra GJ, Bouwmeester R, Hoenderop JG, Bindels RJ. HNF-1B specifically regulates the transcription of the gammaa-subunit of the Na+/K+-ATPase. Biochem Biophys Res Commun404: 284-290, 2011.
156. Feske S, Skolnik EY, Prakriya M. Ion channels and transporters in lymphocyte function and immunity. Nature Rev Immunol 12: 532-547, 2012.
157. Finton CK, Bjorkland S, Zaloga GP, Uddin DE, Chernow B. Gentamicin-induced hypomagnesemia. Am Surgeon49: 576-578, 1983.
158. Fiorica V. Contribution of Activity to the Circadian Rhythm in Excretion of Magnesium and Calcium. Washington, DC: Federal Aviation Administration, Department of Transportation, Office of Aviation Medicine, 1968.
159. Fisher RS, Kaplan PW, Krumholz A, Lesser RP, Rosen SA, Wolff MR. Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin Neuropharmacol11: 537-544, 1988.
160. Folsom AR, Hong CP. Magnesium intake and reduced risk of colon cancer in a prospective study of women. Am J Epidemiol163: 232-235, 2006.
161. Fonseca FA, Paiva TB, Silva EG, Ihara SS, Kasinski N, Martinez TL, Filho EE. Dietary magnesium improves endothelial dependent relaxation of balloon injured arteries in rats. Atherosclerosis 139:237-242, 1998.
162. Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. IntJ Epidemiol28: 645-651, 1999.
163. Ford ES, Mokdad AH. Dietary magnesium intake in a national sample of US adults. J Nutr133: 2879-2882, 2003.
164. Fordtran JS, Rector FC Jr, Carter NW. The mechanisms of sodium absorption in the human small intestine.J Clin Invest 47: 884-900, 1968.
165. Gamba G, Saltzberg SN, Lombardi M, Miyanoshita A, Lytton J, Hediger MA, Brenner BM, Hebert SC. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA90: 2749-2753, 1993.
166. Garfinkel L, Garfinkel D. Magnesium regulation of the glycolytic pathway and the enzymes involved. Magnesium4: 60-72, 1985.
167. Garland HO, Birdsey TJ, Davidge CG, McLaughlin JT, Oakes LM, Smith AJ, Harpur ES. Effects of gentamicin, neomycin and tobramycin on renal calcium and magnesium handling in two rat strains. Clin Exp Pharmacol Physiol 21: 109-115, 1994.
168. Garrison SR, Allan GM, Sekhon RK, Musini VM, Khan KM. Magnesium for skeletal muscle cramps. Cochrane Database Systematic Rev9: CD009402, 2012.
169. Gearhart MO, Sorg TB. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Ann Pharmacother27: 285-289, 1993.
170. Gelfand EW. Role of histamine in the pathophysiology of asthma: immunomodulatory and anti-inflammatory activities of H1-receptor antagonists. Am J Med 113 Suppl 9: 2S-7S, 2002.
171. George MS, Rosenstein D, Rubinow DR, Kling MA, Post RM. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. Psychiatry Res51:139-146, 1994.
172. Geven WB, Monnens LA, Willems HL, Buijs WC, ter Haar BG. Renal magnesium wasting in two families with autosomal dominant inheritance. Kidney Int 31: 1140–1144, 1987.
173. Geven WB, Monnens LA, Willems JL, Buijs W, Hamel CJ. Isolated autosomal recessive renal magnesium loss in two sisters. Clin Genet32: 398-402, 1987.
174. Gilliland FD, Berhane KT, Li YF, Kim DH, Margolis HG. Dietary magnesium, potassium, sodium, and children’s lung function. American journal ofepidemiol 155: 125-131, 2002.
175. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians79: 221-235, 1966.
176. Glaudemans B, van derWijst J, Scola RH, Lorenzoni PJ, Heister A, van der Kemp AW, Knoers NV, Hoenderop JG, Bindels RJ. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest119: 936-942, 2009.
177. Godron A, Harambat J, Boccio V, Mensire A, May A, Rigothier C, Couzi L, Barrou B, Godin M, Chauveau D, Faguer S, Vallet M, Cochat P, Eckart P, Guest G, Guigonis V, Houillier P, Blanchard A, Jeunemaitre X, Vargas-Poussou R. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. ClinJ Am Soc Nephrol 7: 801-809, 2012.
178. Goldman RD, Koren G. Amphotericin B nephrotoxicity in children.J Pediatr Hematol/ Oncol 26: 421-426, 2004.
179. Gomez-Hernandez JM, Lorra C, Pardo LA, Stuhmer W, Pongs O, Heinemann SH, Elliott AA. Molecular basis for different pore properties of potassium channels from the rat brain Kv1 gene family. Pflügers Arch434: 661-668, 1997.
180. Gong Y, Renigunta V, Himmerkus N, Zhang J, Renigunta A, Bleich M, Hou J. Clau-din-14 regulates renal Ca2+ transport in response to CaSR signalling via a novel microRNA pathway. EMBOJ 31: 1999-2012, 2012.
181. Gorji A, Scheller D, Straub H, Tegtmeier F, Köhling R, Höhling JM, Tuxhorn I, Ebner A, Wolf P, Werner Panneck H, Oppel F, Speckmann EJ. Spreading depression in human neocortical slices. Brain Res 906: 74-83, 2001.
182. Goytain A, Hines RM, El-Husseini A, Quamme GA. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem282: 8060-8068, 2007.
183. Goytain A, Hines RM, Quamme GA. Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions, palmitoyl acyltransferase and Mg2+ transport. J Biol Chem283: 33365-33374, 2008.
184. Goytain A, Quamme GA. Functional characterization of ACDP2 (ancient conserved domain protein), a divalent metal transporter. Physiol Genomics22: 382-389, 2005.
185. Goytain A, Quamme GA. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters. Physiol Genomics21: 337-342, 2005.
186. Goytain A, Quamme GA. Identification and characterization of a novel family of membrane magnesium transporters, MMgT1 and MMgT2. Am J Physiol Cell Physiol 294: C495-C502, 2008.
187. Goytain A, Quamme GA. Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties. BMC Genomics6: 48, 2005.
188. Gradon JD, Fricchione L, Sepkowitz D. Severe hypomagnesemia associated with pentamidine therapy. Rev Infect Dis13: 511–512, 1991.
189. Graham LA, Caesar JJ, Burgen AS. Gastrointestinal absorption and excretion of Mg28 in man. Metabolism Clin Exp 9: 646-659, 1960.
190. Grant AO. Cardiac ion channels. Circ Arrhythmia Electrophysiol2: 185-194, 2009.
191. Green L, Kim CH, Bustamante C, Tinoco I Jr. Characterization of the mechanical unfolding of RNA pseudoknots. J Mol Biol 375: 511-528, 2008.
192. Greger R, Velazquez H. The cortical thick ascending limb and early distal convoluted tubule in the urinary concentrating mechanism. Kidney Int31: 590-596, 1987.
193. Greising SM, Gransee HM, Mantilla CB, Sieck GC. Systems biology of skeletal muscle: fiber type as an organizing principle. Wiley Interdisciplinary Rev Systems Biol Med4: 457-473, 2012.
194. Gresh L, Fischer E, Reimann A, Tanguy M, Garbay S, Shao X, Hiesberger T, Fiette L, Igarashi P, Yaniv M, Pontoglio M. A transcriptional network in polycystic kidney disease. EMBOJ 23: 1657-1668,2004.
195. Grew N. A Treatise of the Nature and Use of the Bitter Purging Salt Contain’d in Epsom, and Such Other Waters. London: [s.n.], 1697.
196. Groenestege WM, Hoenderop JG, van den Heuvel L, Knoers N, Bindels RJ. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol17: 1035-1043,2006.
197. Groenestege WM, Thebault S, van der Wijst J, van den Berg D, Janssen R, Tejpar S, van den Heuvel LP, van Cutsem E, Hoenderop JG, Knoers NV, Bindels RJ. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 117: 2260-2267, 2007.
198. Group TETC. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet345: 1455-1463, 1995.
199. Grubbs RD. Effect of epidermal growth factor on magnesium homeostasis in BC3H1 myocytes. Am J Physiol Cell Physiol260: C1158-C1164, 1991.
200. Gruber H, Ingram J, Norton H, Wei L, Frausto A, Mills B, Rude R. Alterations in growth plate and articular cartilage morphology are associated with reduced SOX9 localization in the magnesium-deficient rat. Biotechnic Histochem79: 45-52, 2004.
201. Gu WJ, Wu ZJ, Wang PF, Aung LH, Yin RX. Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials. Trials13: 41, 2012.
202. Gueux E, Rayssiguier Y. The effect of magnesium deficiency on glucose stimulated insulin secretion in rats. Horm Metab Res15:594-597, 1983.
203. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol297: C493-C502, 2009.
204. Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care17: 460-461, 1994.
205. Gullner HG, Gill JR Jr, Bartter FC. Correction of hypokalemia by magnesium repletion in familial hypokalemic alkalosis with tubulopathy. Am J Med71: 578-582, 1981.
206. Gunther T. The biochemical function of Mg2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnesium Res23: 5-18, 2010.
207. Gunzel D, Amasheh S, Pfaffenbach S, Richter JF, Kausalya PJ, Hunziker W, Fromm M. Claudin-16 affects transcellular Cl~ secretion in MDCK cells. J Physiol 587: 3777-3793, 2009.
208. Gunzel D, Stuiver M, Kausalya PJ, Haisch L, Krug SM, Rosenthal R, Meij IC, Hunziker W, Fromm M, Muller D. Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J Cell Sci122: 1507-1517, 2009.
209. Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev93: 525-569, 2013.
210. Gupta A, Eastham KM, Wrightson N, Spencer DA. Hypomagnesaemia in cystic fibrosis patients referred for lung transplant assessment. J Cystic Fibrosis6: 360-362,2007.
211. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am HeartJ153: 891-899, 2007.
212. Gupta SK, Manhas AS, Gupta VK, Bhatt R. Serum magnesium levels in idiopathic epilepsy. TheJ Assoc Physicians India42: 456-457, 1994.
213. Gur A, Colpan L, Nas K, Cevik R, Sarac J, Erdogan F, Duz MZ. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab20: 39-43, 2002.
214. Guther T, Vormann J, Forster R. Regulation of intracellular magnesium by Mg2+ efflux. Biochem Biophys Res Commun119: 124-131,1984.
215. Hall RC, Joffe JR. Hypomagnesemia. Physical and psychiatric symptoms. JAMA 224: 1749-1751, 1973.
216. Hardwick LL, Jones MR, Buddington RK, Clemens RA, Lee DB. Comparison of calcium and magnesium absorption: in vivo and in vitro studies. Am J Physiol Gastrointest Liver Physiol259: G720-G726, 1990.
217. Hardy S, Uetani N, Wong N, Kostantin E, Labbe DP, Begin LR, Mes-Masson A, Miranda-Saavedra D, Tremblay ML. The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis. Oncogene2014; doi:10.1038/onc.2014.33.
218. Hashimoto T, Hara A, Ohkubo T, Kikuya M, Shintani Y, Metoki H, Inoue R, Asayama K, Kanno A, Nakashita M, Terata S, Obara T, Hirose T, Hoshi H, Totsune K, Satoh H, Imai Y. Serum magnesium, ambulatory blood pressure, and carotid artery alteration: the Ohasama study. Am J Hypertens 23: 1292-1298, 2010.
219. Hashimoto Y, Nishimura Y, Maeda H, Yokoyama M. Assessment of magnesium status in patients with bronchial asthma. J Asthma 37: 489-496, 2000.
220. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emergency Med J19: 57-62, 2002.
221. Haury VG. Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulfate. J Lab Clin Med26: 340-344, 1940.
222. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, Jacobs DR Jr, Savage PJ. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113: 1675-1682,2006.
223. World Health Organization, Department of Reproductive Health and Research. Managing Complications in Pregnancy and Childbirth: A Guide for Midwives and Doctors. World Health Organization, 2003.
224. Heaton F, Pyrah L, Beresford C, Bryson R, Martin D. Hypomagnesaemia in chronic alcoholism. Lancet280: 802-805, 1962.
225. Hershko A, Mamont P, Shields R, Tomkins GM. “Pleiotypic response.” Nature New Biol232: 206-211, 1971.
226. Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Alimentary Pharmac Ther 36: 405-413, 2012.
227. Himmerkus N, Shan Q, Goerke B, Hou J, Goodenough DA, Bleich M. Salt and acid-base metabolism in claudin-16 knockdown mice: impact for the pathophysiology of FHHNC patients. Am J Physiol Renal Physiol295: F1641–F1647, 2008.
228. Hirose M, Kobayashi M, Sudo S, Nakanishi K, Noda Y. Hemodialysis for toxic hypermagnesemia caused by intravenous magnesium in a woman with eclampsia and renal insufficiency. A case report. J Reprod Med47: 1050-1052, 2002.
229. Hirota K, Sato T, Hashimoto Y, Yoshioka H, Ohtomo N, Ishihara H, Matsuki A. Relaxant effect of magnesium and zinc on histamine-induced bronchoconstriction in dogs. Crit Care Med27: 1159-1163, 1999.
230. Hirschfelder AD, Haury VG. Clinical manifestations of high and low plasma magnesium: dangers of epsom salt purgation in nephritis. JAMA102: 1138-1141, 1934.
231. Ho KM. Intravenous magnesium for cardiac arrhythmias: jack of all trades. Magnesium Res21: 65-68, 2008.
232. Hoane MR. Assessment of cognitive function following magnesium therapy in the traumatically injured brain. Magnesium Res20: 229-236, 2007.
233. Hoenderop JG, Bindels RJ. Calciotropic and magnesiotropic TRP channels. Physiology23: 32-40, 2008.
234. Hoenderop JG, Bindels RJ.. Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol 16: 15-26,2005.
235. Hoenderop JG, Nilius B, Bindels RJ. ECaC: the gatekeeper of transepithelial Ca2+ transport. Biochim Biophys Acta1600: 6-11, 2002.
236. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78: 1346-1353, 2012.
237. Hollifield JW. Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy. Am J Med80: 8-12, 1986.
238. Holroyde MJ, Potter JD, Solaro RJ. The calcium binding properties of phosphorylated and unphosphorylated cardiac and skeletal myosins. J Biol Chem 254: 6478-6482, 1979.
239. Hong BZ, Kang HS, So JN, Kim HN, Park SA, Kim SJ, Kim KR, Kwak YG. Vascular endothelial growth factor increases the intracellular magnesium. Biochem Biophys Res Commun347: 496-501, 2006.
240. Hong BZ, Park SA, Kim HN, Ma TZ, Kim HG, Kang HS, Kim HG, Kwak YG. Basic fibroblast growth factor increases intracellular magnesium concentration through the specific signaling pathways. Molecules Cells28: 13-17, 2009.
241. Hoorn EJ, Walsh SB, McCormick JA, Furstenberg A, Yang CL, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nature Med 17: 1304-1309,2011.
242. Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y. Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome. J Am Coll Nutr23: 497S-500S, 2004.
243. Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatrics Int48: 112-117, 2006.
244. Hou J, Paul DL, Goodenough DA. Paracellin-1 and the modulation of ion selectivity of tight junctions.J Cell Sci 118: 5109-5118, 2005.
245. Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, Waldegger S, Goodenough DA Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci USA106: 15350-15355, 2009.
246. Hou J, Renigunta A, Konrad M, Gomes AS, Schneeberger EE, Paul DL, Waldegger S, Goodenough DA. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest118: 619-628, 2008.
247. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol18: 2649-2652, 2007.
248. Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBOJ16:5572-5581, 1997.
249. Hubner CA, Holthoff K. Anion transport and GABA signaling. Front Cell Neurosci7: 177, 2013.
250. Hurd TW, Otto EA, Mishima E, Gee HY, Inoue H, Inazu M, Yamada H, Halbritter J, Seki G, Konishi M, Zhou W, Yamane T, Murakami S, Caridi G, Ghiggeri G, Abe T, Hildebrandt F. Mutation of the Mg2+ transporter SLC41A1 results in anephronoph-thisis-like phenotype.J Am Soc Nephrol24: 967-977, 2013.
251. Hutchison AJ, Wilkie M. Use of magnesium as a drug in chronic kidney disease. Clin KidneyJ5: i62-i70, 2012.
252. Huycke MM, Naguib MT, Stroemmel MM, Blick K, Monti K, Martin-Munley S, Kaufman C. A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection. Antimicrobial Agents Chemother44: 2143-2148, 2000.
253. Ikari A, Kano T, Suketa Y. Magnesium influx enhanced by nitric oxide in hypertensive rat proximal tubule cells. Biochem Biophys Res Commun 294: 710-713, 2002.
254. Ikari A, Sanada A, Sawada H, Okude C, Tonegawa C, Sugatani J. Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells. Biochim Biophys Acta 1808: 1502-1508,2011.
255. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol1: 383-386, 2002.
256. Iseri LT, French JH. Magnesium: nature’s physiologic calcium blocker. Am HeartJ108: 188-193, 1984.
257. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, Inaba M, Nishizawa Y. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol68: 222–227, 2007.
258. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnesium Res20: 237-244, 2007.
259. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr78: 737-750, 1997.
260. Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res48: 754-758, 2000.
261. Jee SH, Miller ER, 3rd Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens15: 691-696, 2002.
262. Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain130: 2484-2493, 2007.
263. Jiang J, Li MH, Inoue K, Chu XP, Seeds J, Xiong ZG. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res67: 10929-10938, 2007.
264. Jiang SP, Wu YM, Guo SE, Lv ZQ. Decreased renal mRNA expression of TRPM6 is associated with hypomagnesemia in C57BL/6 asthmatic mice. Eur Rev Med Pharmacol Sci14: 935-940, 2010.
265. Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, Clapham DE. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science322: 756-760, 2008.
266. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr45: 469-475, 1987.
267. Kahraman S, Ozgurtas T, Kayali H, Atabey C, Kutluay T, Timurkaynak E. Monitoring of serum ionized magnesium in neurosurgical intensive care unit: preliminary results. Clin Chim Acta334: 211-215, 2003.
268. Kang HS, Kerstan D, Dai L, Ritchie G, Quamme GA. Aminoglycosides inhibit hormone-stimulated Mg2+ uptake in mouse distal convoluted tubule cells. CanJ Physiol Pharmacol78: 595-602, 2000.
269. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Internal Med 159: 2151-2159, 1999.
270. Karandish M, Tamimi M, Shayesteh AA, Haghighizadeh MH, Jalali MT. The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease. J Res Med Sci18: 2013.
271. Karbach U. Cellular-mediated and diffusive magnesium transport across the descending colon of the rat. Gastroenterology96: 1282-1289, 1989.
272. Karbach U, Rummel W. Cellular and paracellular magnesium transport across the terminal ileum of the rat and its interaction with the calcium transport. Gastroenterology98: 985-992, 1990.
273. Katzberg HD, Khan AH, So YT.Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology74: 691-696, 2010.
274. Kawasaki T, Itoh K, Kawasaki M. Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension. Hypertension Res 21: 235-243, 1998.
275. Kazaks AG, Uriu-Adams JY, Albertson TE, Stern JS. Multiple measures of magnesium status are comparable in mild asthma and control subjects. J Asthma43: 783-788, 2006.
276. Kelsen S, HallJE,Chade AR. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease. Am J Physiol Renal Physiol301: F218-F225, 2011.
277. Kim BJ, Park EJ, Lee JH, Jeon JH, Kim SJ, So I. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer. Cancer Sci99: 2502-2509, 2008.
278. Kim JH, Gelbard AS, Djordjevic B, Kim SH, Perez AG. Action of daunomycin on the nucleic acid metabolism and viability of HeLa cells. Cancer Res28: 2437-2442, 1968.
279. Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an inter-leukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem271: 28890-28897, 1996.
280. King DE, Mainous AG, 3rd Geesey ME, Woolson RF. Dietary magnesium and C-re-active protein levels. J Am Coll Nutr24: 166-171, 2005.
281. Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, Asci G, Ok E, Passlick-Deetjen J. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dialysis Transplant27: 514-521, 2012.
282. Kleyman TR, Roberts C, Ling BN. A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med122: 103-106, 1995.
283. Knoers NV, Levtchenko EN. Gitelman syndrome. OrphanetJ Rare Dis3: 22, 2008.
284. Kohvakka A, Heinonen L, Pietinen P, Salo H, Eisalo A. Potassium and magnesium balance in thiazide-treated cardiac patients with special reference to diet. Acta Med Scand Suppl 668: 102-109, 1982.
285. Koivisto M, Valta P, Hockerstedt K, Lindgren L. Magnesium depletion in chronic terminal liver cirrhosis. Clin Transplant16: 325-328, 2002.
286. KokkoJP. Proximal tubule potential difference. Dependence on glucose on glucose, HCO 3, and amino acids. J Clin Invest52: 1362-1367, 1973.
287. Kolisek M, Launay P, Beck A, Sponder G, Serafini N, Brenkus M, Froschauer EM, Martens H, Fleig A, Schweigel M. SLC41A1 is a novel mammalian Mg2+ carrier. J Biol Chem 283: 16235-16247,2008.
288. Kolisek M, Nestler A, Vormann J, Schweigel-Rontgen M. Human gene SLC41A1 encodes for the Na+/Mg2+ exchanger. Am J Physiol Cell Physiol302: C318-C326, 2012.
289. Kolisek M, Sponder G, Mastrototaro L, Smorodchenko A, Launay P, Vormann J, Schweigel-Rontgen M. Substitution p A350V in Na+/Mg2+ exchanger SLC41A1, potentially associated with Parkinson’s Disease, is a gain-of-function mutation. PloS One8: e71096, 2013.
290. Komaki F, Akiyama T, Yamazaki T, Kitagawa H, Nosaka S, Shirai M. Effects of intravenous magnesium infusion on in vivo release of acetylcholine and catecholamine in rat adrenal medulla. Auton Neurosci Basic Clin 177: 123-128, 2013.
291. Konishi M. Cytoplasmic free concentrations of Ca2+ and Mg2+ in skeletal muscle fibers at rest and during contraction. JpnJ Physiol48: 421-438, 1998.
292. Konrad M, Schaller A, Seelow D, Pandey AV, Waldegger S, Lesslauer A, Vitzthum H, Suzuki Y, Luk JM, Becker C, Schlingmann KP, Schmid M, Rodriguez-Soriano J, Ariceta G, Cano F, Enriquez R, Juppner H, Bakkaloglu SA, Hediger MA, Gallati S, Neuhauss SC, Nurnberg P, Weber S. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 79: 949-957, 2006.
293. Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnesium Res 21: 101-108, 2008.
294. Kuipers MT, Thang HD, Arntzenius AB. Hypomagnesaemia due to use of proton pump inhibitors-a review. Netherlands J Med67: 169-172, 2009.
295. Kuramoto T, Kuwamura M, Tokuda S, Izawa T, Nakane Y, Kitada K, Akao M, Guenet JL, Serikawa T. A mutation in the gene encoding mitochondrial Mg2+ channel MRS2 results in demyelination in the rat. PLoS Genet7: e1001262, 2011.
296. Lainez S, Schlingmann KP, van der Wijst J, Dworniczak B, van Zeeland F, Konrad M, Bindels RJ, Hoenderop JG. New TRPM6 missense mutations linked to hypomagnesemia with secondary hypocalcemia. Eur J Hum Genet22: 497-504, 2014.
297. Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treatment Rev25: 47-58, 1999.
298. Lambers TT, Bindels RJ, Hoenderop JG. Coordinated control of renal Ca2+ handling. Kidney Int69: 650-654, 2006.
299. Lameris AL, Hess MW, van Kruijsbergen I, Hoenderop JG, Bindels RJ. Omeprazole enhances the colonic expression of the Mg2+ transporter TRPM6. Pflügers Arch65: 1613-1620, 2013.
300. Lameris AL, Huybers S, Kaukinen K, Makela TH, Bindels RJ, Hoenderop JG, Neva-lainen PI. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease. Scand J Gastroenterol 48: 58-69, 2013.
301. Larsson SC, Bergkvist L, Wolk A. Magnesium intake in relation to risk of colorectal cancer in women. JAMA293: 86-89, 2005.
302. Laurant P, Berthelot A. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium. Br J Pharmacol119: 1367-1374, 1996.
303. Le Grimellec C. Micropuncture study along the proximal convoluted tubule. Electrolyte reabsorption in first convolutions. Pflügers Arch354: 133–150, 1975.
304. Ledeganck KJ, Boulet GA, Bogers JJ, Verpooten GA, De Winter BY. The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PloS One8: e57016, 2013.
305. Ledeganck KJ, Boulet GA, Horvath CA, Vinckx M, Bogers JJ, Van Den Bossche R, Verpooten GA, De Winter BY. Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. Am J Physiol Renal Physiol301: F486-F493, 2011.
306. Lee CT, Chen HC, Ng HY, Lai LW, Lien YH. Renal adaptation to gentamicin-induced mineral loss. Am J Nephrol35: 279-286, 2012.
307. Leo AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol7: 359-390, 1944.
308. Leroy J. Necessite du magnesium pour la croissance de la souris. CR Soc Biol94: 431, 1926.
309. Levine J, Stein D, Rapoport A, Kurtzman L. High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology39: 63-70, 1999.
310. Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC, Lenardo MJ. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature475: 471-476, 2011.
311. Li J, Zhang Q, Zhang M, Egger M. Intravenous magnesium for acute myocardial infarction. Cochrane Database Systematic Rev CD002755, 2007.
312. Li M, Du J, Jiang J, Ratzan W, Su LT, Runnels LW, Yue L. Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7.J Biol Chem282: 25817-25830, 2007.
313. Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7.J Gen Physiol 127: 525-537, 2006.
314. Liang RY, Wu W, Huang J, Jiang SP, Lin Y. Magnesium affects the cytokine secretion of CD4(+) T lymphocytes in acute asthma.J Asthma 49: 1012-1015, 2012.
315. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am HeartJ136:480-490, 1998.
316. Lin CY, Tsai PS, Hung YC, Huang CJ. L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesthesia104: 44-51, 2010.
317. Lin JY, Chung SY, Lin MC, Cheng FC. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Sci71: 803-811, 2002.
318. Lindahl T, Adams A, Fresco JR. Renaturation of transfer ribonucleic acids through site binding of magnesium. Proc Natl Acad Sci USA55: 941-948, 1966.
319. Liu C, Yeh J, Aloia J. Magnesium directly stimulates osteoblast proliferation. J Bone Miner Res3: S104, 1988.
320. Loffing J, Vallon V, Loffing-Cueni D, Aregger F, Richter K, Pietri L, Bloch-Faure M, Hoenderop JGJ, Shull GE, Meneton P, Kaissling B. Altered renal distal tubule structure and renal Na+ and Ca2+ handling in a mouse model for Gitelman’s Syndrome. J Am Soc Nephrol15: 2276-2288, 2004.
321. Lostroh AJ, Krahl ME. Magnesium, a second messenger for insulin: ion translocation coupled to transport activity. Adv Enzyme Regul12: 73-81, 1974.
322. Lowenstein FW, Stanton MF. Serum magnesium levels in the United States, 1971-1974.J Am Coll Nutr 5: 399-414, 1986.
323. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48: 927-940, 1995.
324. Mahabir S, Forman MR, Dong YQ, Park Y, Hollenbeck A, Schatzkin A. Mineral intake and lung cancer risk in the NIH-American Association of Retired Persons Diet and Health study. Cancer Epidemiol Biomarkers Prevention19: 1976-1983, 2010.
325. Mahabir S, Wei Q, Barrera SL, Dong YQ, Etzel CJ, Spitz MR, Forman MR. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis29: 949-956, 2008.
326. Maier JA, Bernardini D, Rayssiguier Y, Mazur A. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta1689: 6-12, 2004.
327. Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache44: 885-890, 2004.
328. Mandon B, Siga E, Roinel N, de Rouffignac C. Ca2+, Mg2+ and K+ transport in the cortical and medullary thick ascending limb of the rat nephron: influence of transep-ithelial voltage. Pflügers Arch424: 558-560, 1993.
329. Martin BJ, Milligan K. Diuretic-associated hypomagnesemia in the elderly. Arch Internal Med147: 1768-1771, 1987.
330. Massa F, Garbay S, Bouvier R, Sugitani Y, Noda T, Gubler MC, Heidet L, Pontoglio M, Fischer E. Hepatocyte nuclear factor 1beta controls nephron tubular development. Development 140: 886-896, 2013.
331. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache35: 597-600, 1995.
332. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci89: 633-636, 1995.
333. Mauskop A, Varughese J. Why all migraine patients should be treated with magnesium. J Neural Transm 119: 575-579, 2012.
334. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 309: 261-263, 1984.
335. McCollister RJ, Flink EB, Lewis MD. Urinary excretion of magnesium in man following the ingestion of ethanol. Am J Clin Nutr12: 415-420, 1963.
336. McDonald SD, Lutsiv O, Dzaja N, Duley L. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. IntJ Gynaecol Obstet 118: 90-96, 2012.
337. McNeill DA, Herbein JH, Ritchey SJ. Hepatic gluconeogenic enzymes, plasma insulin and glucagon response to magnesium deficiency and fasting. J Nutr112: 736-743, 1982.
338. Meij IC, Koenderink JB, van Bokhoven H, Assink KF, Groenestege WT, de Pont JJ, Bindels RJ, Monnens LA, van den Heuvel LP, Knoers NV. Dominant isolated renal magnesium loss is caused by misrouting of the Na+,K+-ATPase gamma-subunit Nature Genet 26: 265-266, 2000.
339. Meij IC, van den Heuvel LP, Hemmes S, van der Vliet WA, Willems JL, Monnens LA, Knoers NV. Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in two families with primary renal Mg2+ loss. Nephrol Dialysis Transplantation18: 512-516, 2003.
340. Melichar B, Kralickova P, Hyspler R, Kalabova H, Cerman J Jr, Holeckova P, Studen-tova H, Malirova E. Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab. Hepatogastroenterology59: 366-371, 2012.
341. Michailova AP, Belik ME, McCulloch AD. Effects of magnesium on cardiac excitation-contraction coupling. J Am Coll Nutr 23: 514S-517S, 2004.
342. Milla PJ, Aggett PJ, Wolff OH, Harries JT. Studies in primary hypomagnesaemia: evidence for defective carrier-mediated small intestinal transport of magnesium. Gut20: 1028-1033, 1979.
343. Milner RD, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia3: 47-49, 1967.
344. Mishra NK, Peleg Y, Cirri E, Belogus T, Lifshitz Y, Voelker DR, Apell HJ, Garty H, Karlish SJ. FXYD proteins stabilize Na,K-ATPase: amplification of specific phosphati-dylserine-protein interactions. J Biol Chem 286: 9699-9712, 2011.
345. Mishra R, Rao V, Ta R, Shobeiri N, Hill CE. Mg2+- and MgATP-inhibited and Ca2+/ calmodulin-sensitive TRPM7-like current in hepatoma and hepatocytes. Am J Physiol Gastrointest Liver Physiol297: G687-G694, 2009.
346. Misra VK, Draper DE. On the role of magnesium ions in RNA stability. Biopolymers48: 113-135, 1998.
347. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emergency Med J24: 823-830, 2007.
348. Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol121: 49-60, 2003.
349. Mordike BL, Ebert T. Magnesium: Properties-applications-potential. Materials Sci Eng 302: 37-45, 2001.
350. Morris ME. Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. Magnesium Res5: 303-313, 1992.
351. Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction: a double-blind study. Magnesium3: 346-352, 1984.
352. Moykkynen T, Uusi-Oukari M, HeikkilaJ, Lovinger DM, Luddens H, Korpi ER. Magnesium potentiation of the function of native and recombinant GABA(A) receptors. Neuroreport12:2175-2179, 2001.
353. Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R. Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch Biochem Biophys458: 73-89, 2007.
354. Muir KW. Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. CNS Drugs15: 921-930, 2001.
355. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet363: 439-445,2004.
356. Murakami M, Ishizuka J, Sumi S, Nickols GA, Cooper CW, Townsend CM Jr, Thompson JC. Role of extracellular magnesium in insulin secretion from rat insulinoma cells. Proc Soc Exp Biol Med 200: 490-494, 1992.
357. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol69: 33-39, 2008.
358. Myrdal U, Leppert J, Edvinsson L, Ekman R, Hedner T, Nilsson H, Ringqvist I. Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud’s phenomenon. Clin Physiol 14: 539-546, 1994.
359. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A. LTRPC7isaMg.ATP-regulated divalent cation channel required for cell viability. Nature411: 590-595, 2001.
360. Nair AV, Hocher B, Verkaart S, van Zeeland F, Pfab T, Slowinski T, Chen YP, Schling-mann KP, Schaller A, Gallati S, Bindels RJ, Konrad M, Hoenderop JG. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci USA109: 11324-11329,2012.
361. Nair RR, Nair P. Alteration of myocardial mechanics in marginal magnesium deficiency. Magnesium Res15: 287-306, 2002.
362. Nicar MJ, Pak CY. Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism. Miner Electrolyte Metab 8: 44-51, 1982.
363. Nicholls DG, Sihra TS. Synaptosomes possess an exocytotic pool of glutamate. Nature 321: 772-773, 1986.
364. Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca2+ and Mg2+ transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol15: 549-557, 2004.
365. Nijenhuis T, Hoenderop JG, Loffing J, van der Kemp AW, van Os CH, Bindels RJ. Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int64: 555-564, 2003.
366. Nijenhuis T, Renkema KY, Hoenderop JG, Bindels RJ. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. J Am Soc Nephrol17:617-626, 2006.
367. Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest115: 1651-1658, 2005.
368. Noormohamed FH, Youle MS, Tang B, Martin-Munley S, Gazzard BG, Lant AF. Foscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium in HIV-positive patients. Antiviral Ther1: 172-179, 1996.
369. Nouira S, Bouida W, Grissa MH, Beltaief K, Trimech MN, Boubaker H, Marghli S, Letaief M, Boukef R. Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: a randomized trial. Am J Ther21:152-158, 2014.
370. Novelli F, Malagrino L, Dente FL, Paggiaro P. Efficacy of anticholinergic drugs in asthma. Expert Rev Respir Med6: 309-319, 2012.
371. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature307: 462-465, 1984.
372. Okahira M, Kubota M, Iguchi K, Usui S, Hirano K. Regulation of aquaporin 3 expression by magnesium ion. Eur J Pharmacol588: 26-32, 2008.
373. Okayama H, Aikawa T, Okayama M, Sasaki H, Mue S, Takishima T. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA257: 1076-1078, 1987.
374. Oladipo OO, Ajala MO, Okubadejo N, Danesi MA, Afonja OA. Plasma magnesium in adult Nigerian patients with epilepsy. Nigerian PostgradMedJ10: 234-237, 2003.
375. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther120: 157-171, 2008.
376. Olinger E, Schwaller B, Loffing J, Gailly P, Devuyst O. Parvalbumin: calcium and magnesium buffering in the distal nephron. Nephrol Dialysis Transplantation27: 3988-3994, 2012.
377. Onishi S, Yoshino S. Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med45: 207-210, 2006.
378. Oren S, Rapoport J, Zlotnik M, Brami JL, Heimer D, Chaimovitz C. Extreme hypermagnesemia due to ingestion of Dead Sea water. Nephron47: 199-201, 1987.
379. Orenstein SR, Orenstein DM. Magnesium deficiency in cystic fibrosis. Southern Med J 76: 1586, 1983.
380. Oyanagi K, Kawakami E, Kikuchi-Horie K, Ohara K, Ogata K, Takahama S, Wada M, Kihira T, Yasui M. Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathology26: 115-128, 2006.
381. Pages N, Gogly B, Godeau G, Igondjo-Tchen S, Maurois P, Durlach J, Bac P. Structural alterations of the vascular wall in magnesium-deficient mice. A possible role of gela-tinases A (MMP-2) and B (MMP-9). Magnesium Res 16: 43-48, 2003.
382. Pandey M, Gupta A, Baduni N, Vijfdar H, SinhaS,Jain A. Refractory status epilepticus-magnesium as rescue therapy. Anaesthesia Intensive Care38: 962, 2010.
383. Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nature Rev Neurosci14: 383-400, 2013.
384. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D’Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care12: 265-269, 1989.
385. Pardutz A, Vecsei L. Should magnesium be given to every migraineur? No. J Neural Transm119:581-585,2012.
386. Parry DA, Mighell AJ, El-Sayed W, Shore RC, Jalili IK, Dollfus H, Bloch-Zupan A, Carlos R, Carr IM, Downey LM, Blain KM, Mansfield DC, Shahrabi M, Heidari M, Aref P, Abbasi M, Michaelides M, Moore AT, Kirkham J, Inglehearn CF. Mutations in CNNM4 cause Jalili syndrome, consisting of autosomal-recessive cone-rod dystrophy and amelogenesis imperfecta. Am J Hum Genet84: 266-273, 2009.
387. Parsons AA. Cortical spreading depression: its role in migraine pathogenesis and possible therapeutic intervention strategies. Curr Pain Headache Rep8: 410-416, 2004.
388. Partridge IG. Studies on digestion and absorption in the intestines of growing pigs. 3. Net movements of mineral nutrients in the digestive tract. Br J Nutr 39: 527-537, 1978.
389. Paunier L, Radde IC, Kooh SW, Conen PE, Fraser D. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics41: 385-402, 1968.
390. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am HeartJ160: 464-470, 2010.
391. Pearson PJ, Evora PR, Seccombe JF, Schaff HV. Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thoracic Surg 65: 967-972, 1998.
392. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia16: 257-263, 1996.
393. Pelletier H, Sawaya MR, Kumar A, Wilson SH, Kraut J. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science264: 1891-1903, 1994.
394. Perticone F, Adinolfi L, Bonaduce D. Efficacy of magnesium sulfate in the treatment of torsade de pointes. Am HeartJ112: 847-849, 1986.
395. Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Barni S. Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies. Expert Opin Drug Safety 11 Suppl 1: S9-19, 2012.
396. Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Gobel H, Fischer M. Magnesium in the prophylaxis of migraine-a double-blind placebo-controlled study. Cephalalgia16: 436-440, 1996.
397. Pieper MP. The non-neuronal cholinergic system as novel drug target in the airways. Life Sci91: 1113-1118, 2012.
398. Piskacek M, Zotova L, Zsurka G, Schweyen RJ. Conditional knockdown of hMRS2 results in loss of mitochondrial Mg2+ uptake and cell death. J Cell Mol Med13: 693-700, 2009.
399. Pittenger C, Sanacora G, Krystal JH. The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disorders Drug Targets6: 101–115, 2007.
400. Pokan R, Hofmann P, von Duvillard SP, Smekal G, Wonisch M, Lettner K, Schmid P, Shechter M, Silver B, Bachl N. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med40: 773–778, 2006.
401. Polok B, Escher P, Ambresin A, Chouery E, Bolay S, Meunier I, Nan F, Hamel C, Munier FL, Thilo B, Megarbane A, Schorderet DF. Mutations in CNNM4 cause recessive cone-rod dystrophy with amelogenesis imperfecta. Am J Hum Genet 84: 259–265, 2009.
402. Potter JD, Gergely J. The calcium and magnesium binding sites on troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem 250: 4628–4633, 1975.
403. Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp-Sihota JA, Rowe BH. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Systematic Rev12: CD003898, 2012.
404. Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, Hood K, Williamson P. MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children. Health Technol Assess17: 1–216, 2013.
405. Price MA, Tullius TD. 11. Using hydroxyl radical to probe DNA structure. In: Methods in Enzymology, edited by David M. J. Lilley. New York: Academic, 1992, p. 194–219.
406. Pritchard JA, Pritchard SA. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol123: 543–552, 1975.
407. Quamme GA. Effect of furosemide on calcium and magnesium transport in the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol241: F340–F347, 1981.
408. Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 24: 230 –235, 2008.
409. Quamme GA, Smith CM. Magnesium transport in the proximal straight tubule of the rabbit. Am J Physiol Renal Fluid Electrolyte Physiol246: F544–F550, 1984.
410. Quamme GA, Wong NL, Dirks JH, Roinel N, De Rouffignac C, Morel F. Magnesium handling in the dog kidney: a micropuncture study. Pflügers Arch377: 95–99, 1978.
411. Quigley GJ, Teeter MM, Rich A. Structural analysis of spermine and magnesium ion binding to yeast phenylalanine transfer RNA. Proc Natl Acad Sci USA75: 64–68, 1978.
412. Qureshi T, Melonakos TK. Acute hypermagnesemia after laxative use. Ann Emergency Med28: 552–555, 1996.
413. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache29: 590–593, 1989.
414. Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet1: 234–236, 1986.
415. Regan RF, Jasper E, Guo Y, Panter SS. The effect of magnesium on oxidative neuronal injury in vitro. J Neurochem70: 77–85, 1998.
416. Reichold M, Zdebik AA, Lieberer E, Rapedius M, Schmidt K, Bandulik S, Sterner C, Tegtmeier I, Penton D, Baukrowitz T, Hulton SA, Witzgall R, Ben-Zeev B, Howie AJ, Kleta R, Bockenhauer D, Warth R. KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. Proc Natl Acad Sci USA107: 14490–14495, 2010.
417. Reis MA, Latorraca MQ, Carneiro EM, Boschero AC, Saad MJ, Velloso LA, Reyes FG. Magnesium deficiency improves glucose homeostasis in the rat: studies in vivo and in isolated islets in vitro. Br J Nutr85: 549–552, 2001.
418. Reis MA, Reyes FG, Saad MJ, Velloso LA. Magnesium deficiency modulates the insulin signaling pathway in liver but not muscle of rats. J Nutr130: 133–138, 2000.
419. Renkema KY, Alexander RT, Bindels RJ, Hoenderop JG. Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med40: 82–91, 2008.
420. Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Magnesium Res23: 90–96, 2010.
421. Rodriguez-Moran M, Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes/Metab Res Rev27: 590-596, 2011.
422. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care26: 1147-1152, 2003.
423. Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Arch Biochem Biophys458: 90-102, 2007.
424. Rosanoff A, Plesset MR. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnesium Res26: 93-99, 2013.
425. Rosenecker J, Naundorf S, Rudolph C. Airway surface liquid contains endogenous DNase activity which can be activated by exogenous magnesium. Eur J Med Res14: 304-308, 2009.
426. Rowe BH, Camargo CA Jr. The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulmon Med14: 70-76, 2008.
427. Rubin AH, Terasaki M, Sanui H. Magnesium reverses inhibitory effects of calcium deprivation on coordinate response of 3T3 cells to serum. Proc Natl Acad Sci USA75: 4379-4383, 1978.
428. Rubin AH, Terasaki M, Sanui H. Major intracellular cations and growth control: correspondence among magnesium content, protein synthesis, and the onset of DNA synthesis in BALB/c3T3 cells. Proc Natl Acad Sci USA76: 3917-3921, 1979.
429. Rubin H. Central role for magnesium in coordinate control of metabolism and growth in animal cells. Proc Natl Acad Sci USA72: 3551-3555, 1975.
430. Rubin H. The logic of the Membrane, Magnesium, Mitosis (MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys458: 16-23, 2007.
431. Rubin H. The membrane, magnesium, mitosis (MMM) model of cell proliferation control. Magnesium Res18: 268-274, 2005.
432. Rude RK. Magnesium depletion and hypermagnesemia. PrimerMetabBone Dis Disorders Miner Metab1:2006.
433. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Mills BG. Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. J Nutr134: 79-85, 2004.
434. Rude RK, Oldham SB, Sharp CF Jr, Singer FR. Parathyroid hormone secretion in magnesium deficiency. J Clin Endocrinol Metab47: 800-806, 1978.
435. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporosis Int6: 453-461, 1996.
436. Rukshin V, Shah PK, Cercek B, Finkelstein A, Tsang V, Kaul S. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. Circulation 105: 1970-1975, 2002.
437. Runnels LW, Yue L, Clapham DE. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047, 2001.
438. Sabbagh F, El Tawil Z, Lecerf F, Hulin A, Maurois P, Dartevelle P, Bac P, German-Fattal M. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice. Transplantation86: 436-444, 2008.
439. Sabbagh F, Lecerf F, Maurois P, Bac P, German-Fattal M. Allogeneic activation is attenuated in a model of mouse lung perfused with magnesium-deficient blood. Transplant Immunol16: 200-207, 2006.
440. Sahin G, Ertem U, Duru F, Birgen D, Yuksek N. High prevelance of chronic magnesium deficiency in T cell lymphoblastic leukemia and chronic zinc deficiency in children with acute lymphoblastic leukemia and malignant lymphoma. Leukemia Lymphoma39: 555–562, 2000.
441. Sahni J, Nelson B, Scharenberg AM. SLC41A2 encodes a plasma-membrane Mg2+ transporter. BiochemJ401: 505-513, 2007.
442. Salimi MH, Heughebaert JC, Nancollas GH. Crystal growth of calcium phosphates in the presence of magnesium ions. Langmuir 1: 119-122, 1985.
443. Sanders NN, Franckx H, De Boeck K, Haustraete J, De Smedt SC, Demeester J. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax 61: 962-968, 2006.
444. Sanui H, Rubin AH. Membrane bound and cellular cationic changes associated with insulin stimulation of cultured cells. J Cell Physiol96: 265-278, 1978.
445. Sassen MC, Kim SW, Kwon TH, Knepper MA, Miller RT, Frokiaer J, Nielsen S. Dysregulation of renal sodium transporters in gentamicin-treated rats. Kidney Int70: 1026-1037, 2006.
446. Satake K, Lee JD, Shimizu H, Uzui H, Mitsuke Y, Yue H, Ueda T. Effects of magnesium on prostacyclin synthesis and intracellularfree calcium concentration in vascular cells. Magnesium Res 17: 20-27, 2004.
447. Saver JL. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke. Pharmacotherapy30: 62S-69S, 2010.
448. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke35: e106-108, 2004.
449. Scanlan BJ, Tuft B, Elfrey JE, Smith A, Zhao A, Morimoto M, Chmielinska JJ, Tejero-Taldo MI, MakIu T, Weglicki WB, Shea-Donohue T. Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function. Mol Cell Biochem 306: 59-69, 2007.
450. Schelling JR. Fatal hypermagnesemia. Clin Nephrol 53: 61-65, 2000.
451. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation116: 85-97, 2007.
452. Schilsky RL, Anderson T. Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Internal Med90: 929-931, 1979.
453. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nature Genet31: 166-170, 2002.
454. Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A, Scharenberg AM. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114: 191-200,2003.
455. Schneeberger PR, Heizmann CW. Parvalbumin in rat kidney. Purification and localization. FEBS Lett 201: 51-56, 1986.
456. Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia11: 97-99, 1991.
457. Scholl UI, Choi M, Liu T, Ramaekers VT, Hausler MG, Grimmer J, Tobe SW, Farhi A, Nelson-Williams C, Lifton RP. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci USA 106: 5842-5847, 2009.
458. Schrag D, Chung KY, Flombaum C, Saltz L. Cetuximab therapy and symptomatic hypomagnesemia.J Natl Cancer Inst 97: 1221-1224, 2005.
459. Schultheis PJ, Lorenz JN, Meneton P, Nieman ML, Riddle TM, Flagella M, Duffy JJ, Doetschman T, Miller ML, Shull GE. Phenotype resembling Gitelman’s Syndrome in mice lacking the apical Na+-Cl~ cotransporter of the distal convoluted tubule. J Biol Chem273: 29150-29155, 1998.
460. Schweigel M, Martens H. Magnesium transport in the gastrointestinal tract. Front Biosci5: D666-677, 2000.
461. Secil Y, Unde C, Beckmann YY, Bozkaya YT, Ozerkan F, Basoglu M. Blood pressure changes in migraine patients before, during and after migraine attacks. Pain Pract10: 222–227, 2010.
462. Seelig MS, Elin RJ, Antman EM. Magnesium in acute myocardial infarction: still an open question. Can J Cardiol14: 745-749, 1998.
463. Sha Q, Pearson W, Burcea LC, Wigfall DA, Schlesinger PH, Nichols CG, Mercer RW. Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel. Am J Physiol Renal Physiol295: F91-F99, 2008.
464. Shah GM, Alvarado P, Kirschenbaum MA. Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS. Am J Med89: 380-382, 1990.
465. Shan Q, Himmerkus N, Hou J, Goodenough DA, Bleich M. Insights into driving forces and paracellular permeability from claudin-16 knockdown mouse. Ann NY Acad Sci1165: 148-151, 2009.
466. Shareghi GR, Agus ZS. Magnesium transport in the cortical thick ascending limb of Henle’s loop of the rabbit. J Clin Invest69: 759-769, 1982.
467. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. AmJ Cardiol75: 321-323, 1995.
468. Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. AmJ Cardiol 66: 271-274, 1990.
469. Shechter M, Merz CN, Paul-Labrador M, Meisel SR, Rude RK, Molloy MD, Dwyer JH, Shah PK, Kaul S. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. AmJ Cardiol84: 152-156, 1999.
470. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation102: 2353-2358, 2000.
471. Shen B, Nolan JP, Sklar LA, Park MS. Essential amino acids for substrate binding and catalysis of human flap endonuclease 1.J Biol Chem 271: 9173-9176, 1996.
472. Shiga T, Wajima Z, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. AmJ Med117: 325-333, 2004.
473. Shindo Y, Fujii T, Komatsu H, Citterio D, Hotta K, Suzuki K, Oka K. Newly developed Mg2+-selective fluorescent probe enables visualization of Mg2+ dynamics in mitochondria. PloS One6: e23684, 2011.
474. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain134: 2802-2818, 2011.
475. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schur-man S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP. Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nature Genet 17: 171-178, 1997.
476. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genet13: 183-188, 1996.
477. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP. Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nature Genet14: 152-156, 1996.
478. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP. Para-cellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science285: 103-106, 1999.
479. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nature Genet12:24-30, 1996.
480. Sinert R, Zehtabchi S, Desai S, Peacock P, Altura BT, Altura BM. Serum ionized magnesium and calcium levels in adult patients with seizures. ScandJ Clin Lab Invest67: 317-326, 2007.
481. Singh J, Wisdom DM. Second messenger role of magnesium in pancreatic acinar cells of the rat. Mol Cell Biochem149-150: 175-182, 1995.
482. Singh RB, Pella D, Neki NS, Chandel JP, Rastogi S, Mori H, Otsuka K, Gupta P. Mechanisms of acute myocardial infarction study (MAMIS). Biomed Pharmacotherapy 58 Suppl 1: S111–115, 2004.
483. Skorodin MS, Tenholder MF, Yetter B, Owen KA, Waller RF, Khandelwahl S, Maki K, Rohail T, D’Alfonso N. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. Arch Intern Med155:496-500, 1995.
484. Smith DA, Connick JH, Stone TW. Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice. Br J Pharmacol 97: 475-482, 1989.
485. Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. IntJ Cardiol12: 175-183, 1986.
486. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabetic Med23: 1050-1056, 2006.
487. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet10: 4, 2009.
488. Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr85: 1068-1074, 2007.
489. Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care27: 59-65, 2004.
490. Sood AK, Handa R, Malhotra RC, Gupta BS. Serum, CSF, RBC & urinary levels of magnesium & calcium in idiopathic generalised tonic clonic seizures. IndianJ Med Res98: 152-154, 1993.
491. Steinert JR, Chernova T, Forsythe ID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist16: 435-452, 2010.
492. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnesium Res6: 155-163, 1993.
493. Stohr W, Paulides M, Bielack S, Jurgens H, Koscielniak E, Rossi R, Langer T, Beck JD. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatr Blood Cancer 48: 140-147, 2007.
494. Storchheim F. Status epilepticus treated by magnesium sulphate, injected intrave-nously. JAMA 101: 1313-1314, 1933.
495. Stuiver M, Lainez S, Will C, Terryn S, Gunzel D, Debaix H, Sommer K, Kopplin K, Thumfart J, Kampik NB, Querfeld U, Willnow TE, Nemec V, Wagner CA, Hoenderop JG, Devuyst O, Knoers NV, Bindels RJ, Meij IC, Muller D. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypo-magnesemia. AmJ Hum Genet 88: 333-343,2011.
496. Suarez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia38: 1262-1270, 1995.
497. Sudo GZ, Sanguinetti MC. Intracellular [Mg2+] determines specificity of K+ channel block by a class III antiarrhythmic drug. J Pharmacol Exp Ther276: 951-957, 1996.
498. Suh WC, Leirmo S, Record MT Jr. Roles of Mg2+ in the mechanism of formation and dissociation of open complexes between Escherichia coli RNA polymerase and the lambda PR promoter: kinetic evidence for a second open complex requiring Mg2+. Biochemistry 31: 7815-7825, 1992.
499. Sun Y, Selvaraj S, Varma A, Derry S, Sahmoun AE, Singh BB. Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels.J Biol Chem288: 255-263, 2013.
500. Takata Y, Shu XO, Yang G, Li H, Dai Q, Gao J, Cai Q, Gao YT, Zheng W. Calcium intake and lung cancer risk among female nonsmokers: a report from the Shanghai Women’s Health Study. Cancer Epidemiol Biomarkers Prevention22: 50-57, 2013.
501. Takaya J, Higashino H, Kobayashi Y. Can magnesium act as a second messenger? Current data on translocation induced by various biologically active substances. Magnesium Res13: 139-146,2000.
502. Takezawa R, Schmitz C, Demeuse P, Scharenberg AM, Penner R, Fleig A. Receptor-mediated regulation of the TRPM7 channel through its endogenous protein kinase domain. Proc Natl Acad Sci USA101: 6009-6014,2004.
503. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nature Rev Mol Cell Biol7: 85-96, 2006.
504. Tashiro M, Inoue H, Konishi M. Magnesium homeostasis in cardiac myocytes of mg-deficient rats. PloS One8: e73171, 2013.
505. Taubert K. Magnesium in migraine. Results of a multicenter pilot study. Fortschritte derMedizin 112: 328-330, 1994.
506. Taylor JS, Vigneron DB, Murphy-Boesch J, Nelson SJ, Kessler HB, Coia L, Curran W, Brown TR. Free magnesium levels in normal human brain and brain tumors: 31P chemical-shift imaging measurements at 1.5T. Proc Natl Acad Sci USA88:6810-6814, 1991.
507. Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, Mak IT, Weglicki WB. N-methyl-D-aspartate receptor blockade inhibits cardiac inflammation in the Mg2+-deficient rat. J Pharmacol Exp Ther 311:8-13, 2004.
508. Tejpar S, Piessevaux H, Claes K, Piront P, Hoenderop JG, Verslype C, Van Cutsem E. Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer a prospective study. Lancet Oncol8: 387-394, 2007.
509. Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, Lucas T, Newell DW, Mansfield PN, Machamer JE, Barber J, Dikmen SS. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6: 29-38, 2007.
510. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. Magnesium causes nitric oxide independent coronary artery vasodilation in humans. Heart 86: 212-216, 2001.
511. Teragawa H, Matsuura H, Chayama K, Oshima T. Mechanisms responsible for vasodilation upon magnesium infusion in vivo: clinical evidence. Magnesium Res 15: 241-246, 2002.
512. Terasaki M, Rubin H. Evidence that intracellular magnesium is present in cells at a regulatory concentration for protein synthesis. Proc Natl Acad Sci USA82: 7324-7326, 1985.
513. Thebault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol20: 78-85, 2009.
514. Thebault S, Cao G, Venselaar H, Xi Q, Bindels RJ, Hoenderop JG. Role of the alpha-kinase domain in transient receptor potential melastatin 6 channel and regulation by intracellular ATP. J Biol Chem283: 19999-20007, 2008.
515. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet2: 1116-1120, 1984.
516. Thony B, Neuheiser F, Kierat L, Blaskovics M, Arn PH, Ferreira P, Rebrin I, Ayling J, Blau N. Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbino-lamine dehydratase and transcriptional coactivator (DCoH). Am J Hum Genet 62: 1302-1311, 1998.
517. Thony B, Neuheiser F, Kierat L, Rolland MO, Guibaud P, Schluter T, Germann R, Heidenreich RA, Duran M, de Klerk JB, Ayling JE, Blau N. Mutations in the pterin-4alpha-carbinolamine dehydratase (PCBD) gene cause a benign form of hyperphenylalaninemia. Hum Genet 103: 162-167, 1998.
518. Tietz NW. Clinical Guide to Laboratory Tests. Philadelphia, PA: Saunders, 1995.
519. Tofil NM, Benner KW, Winkler MK. Fatal hypermagnesemia caused by an Epsom salt enema: a case illustration. Southern Medical J98: 253-256, 2005.
520. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol17: 2034-2047, 2006.
521. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disorders4: 195-206,2003.
522. Topol EJ, Lerman BB. Hypomagnesemic torsades de pointes. Am J Cardiol52: 1367-1368, 1983.
523. Tsang HT, Edwards TL, Wang X, Connell JW, Davies RJ, Durrington HJ, O’Kane CJ, Luzio JP, Reid E. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 18: 3805-3821, 2009.
524. Turecky L, Kupcova V, Szantova M, Uhlikova E, Viktorinova A, Czirfusz A. Serum magnesium levels in patients with alcoholic and non-alcoholic fatty liver. Bratislavske Lekarske Listy107: 58-61, 2006.
525. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation 77: 392-397, 1988.
526. Tzivoni D, Keren A, Cohen AM, Loebel H, Zahavi I, Chenzbraun A, Stern S. Magnesium therapy for torsades de pointes. AmJ Cardiol53: 528-530, 1984.
527. Van Angelen AA, Glaudemans B, van der Kemp AW, Hoenderop JG, Bindels RJ. Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypo-magnesaemia in mice. Nephrol Dialysis Transplantation28: 879-889, 2013.
528. Van Angelen AA, van der Kemp AW, Hoenderop JG, Bindels RJ. Increased expression of renal TRPM6 compensates for Mg2+ wasting during furosemide treatment. Clin KidneyJ5: 535-544, 2012.
529. Van den Bergh WM, Algra A, Rinkel GJ. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke35: 644-648, 2004.
530. Van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery52: 276-281, 2003.
531. Van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke36: 1011–1015, 2005.
532. Van den Brandt PA, Smits KM, Goldbohm RA, Weijenberg MP. Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study. Br J Cancer96: 510-513, 2007.
533. Van Laecke S, Van Biesen W, Verbeke F, De Bacquer D, Peeters P, Vanholder R. Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. AmJ Transplant9:2140-2149, 2009.
534. Vargas-Caballero M, Robinson HP. Fast and slow voltage-dependent dynamics of magnesium block in the NMDA receptor: the asymmetric trapping block model. J Neurosci24: 6171-6180, 2004.
535. Vidair C, Rubin H. Evaluation of Mg2+ as an intracellular regulator of uridine uptake. J Cell Physiol108: 317-325, 1981.
536. Vink R, Nechifor M. Magnesium in the Central Nervous System. Adelaide, Australia: Univ. of Adelaide Press, 2011.
537. Vink R, van den Heuvel C. Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics 7: 74-80, 2010.
538. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem279: 19-25, 2004.
539. Volpe SL. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr48: 293-300, 2008.
540. Vosgerau H. Migraine therapy with magnesium glutamate. Therapie der Gegenwart112: 640, 1973.
541. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nature Genet31: 171-174, 2002.
542. Walder RY, Shalev H, Brennan TM, Carmi R, Elbedour K, Scott DA, Hanauer A, Mark AL, Patil S, Stone EM, Sheffield VC. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 6: 1491-1497, 1997.
543. Wang CY, Shi JD, Yang P, Kumar PG, Li QZ, Run QG, Su YC, Scott HS, Kao KJ, She JX. Molecular cloning and characterization of a novel gene family of four ancient conserved domain proteins (ACDP). Gene 306: 37-44, 2003.
544. Wang JJ, Freeman AI, Gaeta JF, Sinks LF. Unusual complications of pentamidine in the treatment of Pneumocystis carinii pneumonia.J Pediatr 77: 311-314, 1970.
545. Wang M, Tashiro M, Berlin JR. Regulation of L-type calcium current by intracellular magnesium in rat cardiac myocytes. J Physiol 555: 383-396, 2004.
546. Wang X, Proud CG. Nutrient control of TORC1, a cell-cycle regulator. Trends Cell Biol19: 260-267, 2009.
547. Watson JD, Crick FH. Molecular structure of nucleic acids: a structure for deoxyri-bose nucleic acid. Nature171: 737-738, 1953.
548. Weber G, Lea MA, Convery HJ, Stamm NB. Regulation of gluconeogenesis and glycolysis: studies of mechanisms controlling enzyme activity. Adv Enzyme Regul5: 257-300, 1967.
549. Weber JD, Gutmann DH. Deconvoluting mTOR biology. Cell Cycle11: 236-248, 2012.
550. Weglicki WB, Dickens BF, Wagner TL, Chmielinska JJ, Phillips TM. Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulatingT lymphocytes from magnesium-deficient mice. Magnesium Res 9: 3-11, 1996.
551. Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res74: 1009-1013, 1994.
552. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. AmJ Physiol Regul Integr Comp Physiol263: R734-R737, 1992.
553. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med38: 1284-1290, 2010.
554. Westhof E, Sundaralingam M. Restrained refinement of the monoclinic form of yeast phenylalanine transfer RNA. Temperature factors and dynamics, coordinated waters, and base-pair propeller twist angles. Biochemistry 25: 4868-4878, 1986.
555. Weston PG. Magnesium as a sedative. AmJ Psychiatry78: 637-638, 1922.
556. White RE, Hartzell HC. Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes. Science239: 778-780, 1988.
557. Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. AmJ Hypertens6: 41-45, 1993.
558. Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, Ploplis B, Belyantseva I, Ben-Yosef T, Liburd NA, Morell RJ, Kachar B, Wu DK, Griffith AJ, Riazuddin S, Friedman TB. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell104: 165-172,2001.
559. Wiles ME, Wagner TL, Weglicki WB. Effect of acute magnesium deficiency (MgD) on aortic endothelial cell (EC) oxidant production. Life Sci 60: 221-236, 1997.
560. Wilkinson R, Lucas GL, Heath DA, Franklin IM, Boughton BJ. Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides. Br Med J292: 818-819, 1986.
561. Williams BA, Beatch GN. Magnesium shifts voltage dependence of activation of delayed rectifier I(K) in guinea pig ventricular myocytes. AmJ Physiol Heart Circ Physiol272: H1292-H1301, 1997.
562. Wisdom DM, Salido GM, Baldwin LM, Singh J. The role of magnesium in regulating CCK-8-evoked secretory responses in the exocrine rat pancreas. Mol Cell Biochem154: 123-132, 1996.
563. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnesium Res24: 163-180, 2011.
564. Wolf FI, Fasanella S, Tedesco B, Torsello A, Sgambato A, Faraglia B, Palozza P, Boninsegna A, Cittadini A. Regulation of magnesium content during proliferation of mammary epithelial cells (HC-11). Front Biosci9: 2056-2062, 2004.
565. Wolf MT, Dotsch J, Konrad M, Boswald M, Rascher W. Follow-up of five patients with FHHNC due to mutations in the Paracellin-1 gene. Pediatr Nephrol 17: 602-608, 2002.
566. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke41: 921-926, 2010.
567. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet339: 1553-1558, 1992.
568. Worthington V. Nutritional quality of organic versus conventional fruits, vegetables, and grains. J Altern Complement Med 7: 161-173, 2001.
569. Wright FS. Increasing magnitude of electrical potential along the renal distal tubule. Am J Physiol220: 624-638, 1971.
570. Xu JZ, Hall AE, Peterson LN, Bienkowski MJ, Eessalu TE, Hebert SC. Localization of the ROMK protein on apical membranes of rat kidney nephron segments. Am J Physiol Renal Physiol273: F739-F748, 1997.
571. Yago MD, Manas M, Singh J. Intracellular magnesium: transport and regulation in epithelial secretory cells. Front Biosci5: D602-618, 2000.
572. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. Acute-onset hypo-magnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone. J Bone Miner Metab29: 752-755, 2011.
573. Yamazaki D, Funato Y, Miura J, Sato S, Toyosawa S, Furutani K, Kurachi Y, Omori Y, Furukawa T, Tsuda T, Kuwabata S, Mizukami S, Kikuchi K, Miki H. Basolateral Mg2+ extrusion via CNNM4 mediates transcellular Mg2+ transport across epithelia: a mouse model. PLoS Genet 9: e1003983, 2013.
574. Yan Y, Tian J, Mo X, Zhao G, Yin X, Pu J, Zhang B. Genetic variants in the RAB7L1 and SLC41A1 genes of the PARK16 locus in Chinese Parkinson’s disease patients. IntJ Neurosci 121: 632-636, 2011.
575. Yang L, Arora K, Beard WA, Wilson SH, Schlick T. Critical role of magnesium ions in DNA polymerase beta’s closing and active site assembly. J Am Chem Soc126: 8441-8453, 2004.
576. Yang L, Frindt G, Palmer LG. Magnesium modulates ROMK channel-mediated potassium secretion. J Am Soc Nephrol21: 2109-2116, 2010.
577. Yang Y, Li Q, Ahmad F, Shuaib A. Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. Neurosci Lett285: 119-122, 2000.
578. Yasui M, Kihira T, Ota K. Calcium, magnesium and aluminum concentrations in Parkinson’s disease. Neurotoxicology 13:593-600, 1992.
579. Yee NS, Zhou W, Liang IC. Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer. Disease Models Mechanisms4: 240-254, 2011.
580. Young FB, Franciosi S, Spreeuw A, Deng Y, Sanders S, Tam NC, Huang K, Singaraja RR, Zhang W, Bissada N, Kay C, Hayden MR. Low levels of human HIP14 are sufficient to rescue neuropathological, behavioural, and enzymatic defects due to loss of murine HIP14 in Hip14—/— mice. PloS One 7: e36315, 2012.
581. Young GL, Jewell D. Interventions for leg cramps in pregnancy. Cochrane Database Systematic RevCD000121, 2002.
582. Zafar S, Hussain A, Liu Y, Lewis D, Inesi G. Specificity of ligand binding to transport sites: Ca2+ binding to the Ca2+ transport ATPase and its dependence on H+ and Mg2+. Arch Biochem Biophys476: 87-94, 2008.
583. Zaloga GP, Chernow B, Pock A, Wood B, Zaritsky A, Zucker A. Hypomagnesemia is a common complication of aminoglycoside therapy. Surg Gynecol Obstet158: 561-565, 1984.
584. Zaman F, Abreo K. Severe hypermagnesemia as a result of laxative use in renal insufficiency. Southern Med J96: 102-103, 2003.
585. Zhang W, Iso H, Ohira T, Date C, Tamakoshi A. Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study. Atherosclerosis221: 587-595, 2012.
586. Zhang Z, Yu H, Huang J, Faouzi M, Schmitz C, Penner R, Fleig A. The TRPM6 kinase domain determines the MgATP sensitivity of TRPM7/M6 heteromeric ion channels. J Biol Chem289: 5217-5227, 2014.
587. Zhou H, Clapham DE. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc Natl Acad Sci USA106: 15750-15755, 2009.
588. Zhou Q, Olinescu RM, Kummerow FA. Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial endothelial cells. Magnesium Res12: 19-29, 1999.
589. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e385-484, 2006.
590. Zsurka G, Gregan J, Schweyen RJ. The human mitochondrial Mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics72: 158-168, 2001.
591. Zumkley H, Bertram HP, Preusser P, Kellinghaus H, Straub C, Vetter H. Renal excretion of magnesium and trace elements during cisplatin treatment. Clin Nephrol17: 254-257, 1982.
592. Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol9: 954-972, 1966.
593. Zwillinger L. Über die Magnesiumwirkung auf das Herz. Klin Wochenschr 14: 1429-1433, 1935.